Table 1.
Progression of blood tests
| Test (reference range) | Presentation (December 2010) | Day 32 | March 2011 | November 2011 (before first ERCP) | July 2012 (peak liver dysfunction) | November 2013 |
|---|---|---|---|---|---|---|
| BIL (0–21 µmol/L) | 9 | 124 | 68 | 179 | 323 | 78 |
| ALP (35–129 IU/L) | 119 | 1057 | 2297 | 616 | 1048 | 477 |
| ALT (4–45 IU/L) | 112 | 247 | 171 | 229 | 248 | 333 |
| GGT (4–72 IU/L) | 655 | 1278 | 546 | 798 | 909 | 1070 |
| INR (0.8–1.2) | 0.94 | 1.12 | 1.1 | 1.2 | 1.2 | 1.0 |
| CR (59–104 µmol/L) | 269 | 134 | 78 | 65 | 71 | 72 |
| WBC (4–11×109) | 13.1 | 15.7 | 16.0 | 13.7 | 13.7 | 9.2 |
| CRP (0–4 mg/L) | 200 | 200 | 63 | 103 | 87 | 5 |
ALP, alkaline phosphatase; ALT, alanine aminotransferase; BIL, bilirubin; CR, creatinine; CRP, C-reactive protein; ERCP, endoscopic retrograde cholangiopancreatography; GGT, γ-glutamyl transpeptidase; INR, International normalised ratio; WBC, white blood cell count.